ウィスコンシンにおける乳がんの臨床試験
ウィスコンシン内の拠点で、乳がんに関する44件の研究が参加者を募集しています。
ウィスコンシン内の都市
- Milwaukee23件の研究
- Madison22件の研究
- Green Bay7件の研究
- Sheboygan6件の研究
- La Crosse6件の研究
- Stevens Point5件の研究
- Oshkosh5件の研究
- Wausau5件の研究
- Eau Claire5件の研究
- Manitowoc4件の研究
- Neenah4件の研究
- Kenosha4件の研究
- Racine4件の研究
- Watertown4件の研究
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- 他50件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- University of Wisconsin, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07102381Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Wisconsin Institute for Medical Research, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0039), Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07060807A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- University of Wisconsin-Madison ( Site 0024), Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06966700A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040), Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312176Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Milwaukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- University of Wisconsin, Madison
被験者募集中
18歳以上 · 全性別 · 2026/09/23更新 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- ThedaCare Physicians - Appleton North, Appleton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Wisconsin - Carbone Cancer Center, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Medical College of Wisconsin, Milwaukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07173751A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Mayo Clinic Health System - Eau Claire, Eau Claire
- Mayo Clinic Health System - La Crosse, La Crosse
- University of Wisconsin Carbone Cancer Center- University Hospital, Madison
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
- Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07405801Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Wisconsin-Madison Carbone Cancer Center, Madison
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07287917Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- University of Wisconsin Carbone Cancer Center- University Hospital, Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06982521Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Gunderson Health, La Crosse
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07211178Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
- University of Wisconsin, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT04886531The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- 他59件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Sheboygan Cancer & Blood Specialists, Sheboygan
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612Study of 18F-FFNP Breast PET/MRI
- UW Carbone Cancer Center, Madison
被験者募集中第2相
18歳以上 · 女性 · 2026/08/31更新 · NCT06086704Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017Biomarkers to Detect Endocrine Therapy Resistance
- UW Carbone Cancer Center, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06067503Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
被験者募集中
65歳以上 · 全性別 · 2026/08/20更新 · NCT07227077Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
被験者募集中
18歳以上 · 全性別 · 2026/08/05更新 · NCT06106477E-Mindfulness Approaches for Living After Breast Cancer
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Cancer Care - Berlin, Berlin
- 他21件
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
- University of Wisconsin Carbone Cancer Center, Madison
被験者募集中第2相
40歳以上 · 女性 · 2026/06/11更新 · NCT03936478De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Langlade Hospital and Cancer Center, Antigo
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- 他43件
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Aspirus Langlade Hospital, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Saint Elizabeth Hospital, Appleton
- 他61件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Medical College of Wisconsin, Milwaukee
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/05更新 · NCT04075305Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/25更新 · NCT02926690Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- University of Wisconsin, Madison
被験者募集中第4相
18歳〜64歳 · 全性別 · 2026/01/22更新 · NCT04373564EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Aurora Cancer Care - Wauwatosa, Wauwatosa
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/20更新 · NCT06401421SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳以上 · 女性 · 2025/10/14更新 · NCT06361940ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。